Get Flat 20% Discount on All Medications
  • Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      FDA Accepts Glenmark's Review Plea for Painkiller


      BANGALORE -- Glenmark Pharmaceuticals Ltd. said Wednesday the U.S. Food & Drug Administration has accepted for review a new drug application for painkiller oxycodone hydrochloride capsules and liquid solution, which could potentially be a significant revenue earner for the Indian drug maker.

      The application to the FDA was made earlier by Glenmark's partner in the U.S., Lehigh Valley Technologies.

      The painkiller is part of a "grandfathered products" list, which includes drugs that have been available in the U.S. before the current food and drug regulations came into force in 1938 and which are still being sold today, despite not technically having the FDA approval.

      Since 2006, the regulator has changed its policy towards these "grandfathered products". Once a company seeks and receives regulatory approval to make and sell these products, it must remove other versions of the drug from the market--even if they have been on sale, legally, for years.

      U.S. sales for oxycodone hydrochloride capsules and liquid solution in the year ending December 31, 2009, were $16 million as reported by market research firm IMS Health.

      Under current rules, Glenmark could get an FDA approval within 10 months.

      If the company is able to get a regulatory approval, the drug could boost the company's topline in the financial year starting April 1, 2011, Glenmark Chief Executive and Managing Director Glenn Saldanha told television news channel CNBC-TV18.

      Mr. Saldanha said also that the drug could generate "pretty substantial" operating margins.

      April 07, 2010


      Share this Article!

    Back to top^